Refresh
500302 PEL Group (A)
Piramal Enterprises Ltd. LIVE on BSE (View NSE)
Add to watchlist
|
555.80
-13.00
-2.29%
|
HOW HOT IS THIS STOCK?  Last 15 days data © Rediff.com |
Refresh
PEL
Piramal Enterprises Ltd. LIVE on NSE (View BSE)
Add to watchlist
|
555.65
-9.95
-1.76%
|
HOW HOT IS THIS STOCK? Last 15 days data © Rediff.com |
Realtime news for Piramal Enterprises Ltd. (See all 348 news)
24 May 2013, 06:47
Piramal Enterprises Limited - 16 May 2013
Piramal Enterprises Q4 loss increases - 3 day(s) ago
Piramal firm on Voda exit, co may need new partner - 11 May 2013
Bug off - 16 May 2013
Market Voices for Piramal Enterprises Ltd. (See all 105 market voices)
Expert Voices
- 10 May 2013
#Shriram-Transport-Finance-Company-Ltd
:#Piramal-Enterprises-Ltd
has not approached us for board representation. (ET Now)#money
BSE Announcements from Piramal Enterprises Ltd. (See all)
Updates on Press Release dated May 10, 2013 - 15 May 2013
Company details for Piramal Enterprises Ltd.
Report Card
PE Ratios
-42.38
EPS (Rs.)
-13.42
Sales (Rs. Cr)
435.03
Face Value (Rs.)
2
Net Profit
Margin (%)
Margin (%)
9.69
Last Bonus
1:2
Last Dividend(%)
875
Return on
Average Equity
Average Equity
1.17
Research Centre
Results: Quarterly | Half Yearly | Annual
Statements: Balance Sheet | P&L | Cash Flow More: Dividend | Bonus | Share Holding | Capital Structures | Ratios
Statements: Balance Sheet | P&L | Cash Flow More: Dividend | Bonus | Share Holding | Capital Structures | Ratios
Compare Piramal Enterprises Ltd. with other stocks
Apollo Hospitals Enterprise Ltd.
940.35
Aurobindo Pharma Ltd.
182.25
Show more companies Apollo Hospitals Enterprise Ltd.
940.35
Aurobindo Pharma Ltd.
182.25
Biocon Ltd.
279.75
Cadila Healthcare Ltd.
786.55
Cipla Ltd.
415.25
Divi's Laboratories Ltd.
994.65
Dr. Reddy's Laboratories Ltd.
2,056.55
GlaxoSmithKline Pharmaceuticals Ltd.
2,277.45
Glenmark Pharmaceuticals Ltd.
563.00
Ipca Laboratories Ltd.
582.85
Show less companies © 2013 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback